Cargando…
How to prophylactically alleviate postembolization syndrome following transarterial chemoembolization?: Protocol of a double blinded, randomized, placebo-controlled trial
INTRODUCTION: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and most patients in China are diagnosed at the intermediate or later stages, which is not suitable for the first line therapies. Transarterial chemoembolization (TACE) is a commonly selected therapeutic op...
Autores principales: | Pan, Yi, Chang, Rui, He, Zhonglin, Hong, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545327/ https://www.ncbi.nlm.nih.gov/pubmed/33832116 http://dx.doi.org/10.1097/MD.0000000000025360 |
Ejemplares similares
-
Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis
por: Roehlen, Natascha, et al.
Publicado: (2023) -
Jian Pi Li Qi Decoction Alleviated Postembolization Syndrome Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Xu, Litao, et al.
Publicado: (2015) -
Nurses' comfort care of transarterial chemoembolization patients based on their perceptions around postembolization syndrome and symptom interference
por: Kim, Myoung Soo, et al.
Publicado: (2022) -
Efficacy of Phellinus linteus (sanghuang) extract for improving immune functions: Study protocol for a randomized, double-blinded, placebo-controlled pilot trial
por: Jung, Ga Hyeon, et al.
Publicado: (2020) -
Efficacy and safety of ChondroT on knee-osteoarthritis: Protocol for a 8-week, randomized, double-blind, placebo-controlled, multicenter therapeutic exploratory clinical trial
por: Lee, Sangkwan, et al.
Publicado: (2018)